Bicara Therapeutics (BCAX) Q2 2025 Earnings

May 13Confirmed
Q4 2024
Q1 2025
Q2 2025
-1.6
-1.18
-0.75
-0.33

Details

Expected EPS
-0.415
Actual EPS
-0.68
Surprise EPS
-0.27
Surprise Percent
-63.86%

Description

⁨Bicara Therapeutics⁩ (⁦BCAX⁩) has reported earnings of ⁦-0.68⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts